Wolverine Trading
IOVA icon

Wolverine Trading’s Iovance Biotherapeutics IOVA Stock Holding History

Wolverine Trading’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$94.3K Buy
+42,300
New +$99.9K ﹤0.01% 5220
2025
Q2 		– Sell
-25,200
Closed -$89.7K – 5161
2025
Q1 		$89.7K Sell
25,200
-20,000
-44% -$103K ﹤0.01% 4260
2024
Q4 		$324K Sell
45,200
-5,100
-10% -$47.3K ﹤0.01% 3936
2024
Q3 		$483K Buy
50,300
+9,300
+23% +$88.1K ﹤0.01% 3088
2024
Q2 		$329K Sell
41,000
-26,100
-39% -$280K ﹤0.01% 3289
2024
Q1 		$994K Sell
67,100
-14,300
-18% -$166K ﹤0.01% 2208
2023
Q4 		$662K Buy
81,400
+47,900
+143% +$251K ﹤0.01% 2670
2023
Q3 		$152K Buy
33,500
+11,600
+53% +$75.7K ﹤0.01% 3854
2023
Q2 		$154K Buy
21,900
+10,000
+84% +$71.6K ﹤0.01% 3621
2023
Q1 		$73K Sell
11,900
-5,000
-30% -$34.5K ﹤0.01% 3742
2022
Q4 		$108K Buy
16,900
+5,200
+44% +$40.6K ﹤0.01% 3388
2022
Q3 		$112K Sell
11,700
-6,300
-35% -$72.7K ﹤0.01% 3869
2022
Q2 		$196K Sell
18,000
-1,500
-8% -$19.7K ﹤0.01% 3569
2022
Q1 		$326K Buy
19,500
+2,300
+13% +$35.6K ﹤0.01% 3781
2021
Q4 		$334K Sell
17,200
-2,000
-10% -$44K ﹤0.01% 4002
2021
Q3 		$457K Sell
19,200
-17,100
-47% -$403K ﹤0.01% 4069
2021
Q2 		$956K Buy
+36,300
New +$944K ﹤0.01% 2839

Other funds holding IOVA

MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wolverine Trading's IOVA Position: Q3 2025 in Review

Wolverine Trading opened a new position in Iovance Biotherapeutics (IOVA) in Q3 2025: 21,739 shares worth $48.5K. The stake represents ﹤0.01% of the portfolio and ranks #5418 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in IOVA as recently as Q1 2025.

Wolverine Trading first reported a position in IOVA in Q2 2021 and has held it in 15 quarters since. The position peaked at $993K in Q4 2023. 253 funds tracked by Wall St. Rank hold IOVA as of Q3 2025.

  • Wolverine Trading held 21,739 shares of Iovance Biotherapeutics worth $48.5K as of Q3 2025.
  • Iovance Biotherapeutics was a new Wolverine Trading position in Q3 2025.
  • Iovance Biotherapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5418 holding.
  • Wolverine Trading first reported a position in Iovance Biotherapeutics in Q2 2021 and has held it in 15 quarters since.
  • Wolverine Trading's Iovance Biotherapeutics position peaked at $993K in Q4 2023.
  • 253 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.